A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors

Clinical trial NCT05781386 · UNKNOWN

Trial details

NCT number: NCT05781386
Sponsor: Jiangsu Simcere Biologics Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Cutaneous T Cell Lymphoma

Start date: 2022-03-06
Primary completion: 2025-06-30
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.